Cargando…
Evolution of Plant-Made Pharmaceuticals
The science and policy of pharmaceuticals produced and/or delivered by plants has evolved over the past twenty-one years from a backyard remedy to regulated, purified products. After seemingly frozen at Phase I human clinical trials with six orally delivered plant-made vaccines not progressing past...
Autores principales: | Thomas, David R., Penney, Claire A., Majumder, Amrita, Walmsley, Amanda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116187/ https://www.ncbi.nlm.nih.gov/pubmed/21686181 http://dx.doi.org/10.3390/ijms12053220 |
Ejemplares similares
-
Plant-made vaccines in support of the Millennium Development Goals
por: Penney, Claire A., et al.
Publicado: (2011) -
Risk analysis for plant-made vaccines
por: Kirk, Dwayne D., et al.
Publicado: (2005) -
Plant-made pharmaceuticals: exploring studies for the production of recombinant protein in plants and assessing challenges ahead
por: Lee, Juho, et al.
Publicado: (2023) -
Plant‐made pharmaceuticals: from ‘Edible Vaccines’ to Ebola therapeutics
por: Arntzen, Charles
Publicado: (2015) -
The Effect of Plant Tissue and Vaccine Formulation on the Oral Immunogenicity of a Model Plant-Made Antigen in Sheep
por: Pelosi, Assunta, et al.
Publicado: (2012)